Procter & Gamble CO 8-K Filing

Ticker: PG · Form: 8-K · Filed: Nov 3, 2025 · CIK: 80424

Sentiment: neutral

Filing Stats: 812 words · 3 min read · ~3 pages · Grade level 9 · Accepted 2025-11-03 16:23:10

Key Financial Figures

Filing Documents

From the Filing

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 3, 2025 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in charter) Ohio 001-00434 31-0411980 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices and zip code) 513 - 983-1100 Registrant's telephone number, including area code (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, without Par Value PG New York Stock Exchange 0.110% Notes due 2026 PG26D New York Stock Exchange 3.25% EUR Notes due 2026 PG26F New York Stock Exchange 4.875% EUR notes due May 2027 PG27A New York Stock Exchange 1.200% Notes due 2028 PG28 New York Stock Exchange 3.150% EUR Notes due 2028 PG28B New York Stock Exchange 1.250% Notes due 2029 PG29B New York Stock Exchange 1.800% Notes due 2029 PG29A New York Stock Exchange 6.250% GBP notes due January 2030 PG30 New York Stock Exchange 0.350% Notes due 2030 PG30C New York Stock Exchange 0.230% Notes due 2031 PG31A New York Stock Exchange 3.250% EUR Notes due 2031 PG31B New York Stock Exchange 5.250% GBP notes due January 2033 PG33 New York Stock Exchange 3.200% EUR Notes due 2034 PG34C New York Stock Exchange 1.875% Notes due 2038 PG38 New York Stock Exchange 0.900% Notes due 2041 PG41 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item8.01 Other Events. On November 3, 2025, The Procter & Gamble Company (the "Company") closed an underwritten public offering of 500,000,000 aggregate principal amount of 2.900% Notes due November 3, 2033 and 500,000,000 aggregate principal amount of 3.650% Notes due November 3, 2045 under the Company's Registration Statement on Form S-3 (Registration No. 333-275071) (the "Registration Statement"). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference. Additionally, on November 3, 2025, the Company closed an underwritten public offering of $750,000,000 aggregate principal amount of 4.100% Notes due November 3, 2032 and $500,000,000 aggregate principal amount of 4.350% Notes due November 3, 2035 under the Registration Statement. Legal opinions related to these notes are attached hereto as Exhibits (5)(c) and (5)(d) and are incorporated herein by reference. Item9.01 Financial Statements and Exhibits. (d)The following exhibits are being filed with this Current Report on Form 8-K. Exhibit Number Description (5)(a) Opinion of Jennifer Henkel, Esq., Director and Assistant General Counsel of the Company. (5)(b) Opinion of Fried, Frank, Harris, Shriver & Jacobson LLP, which is referred to in the opinion filed as Exhibit (5)(a). (5)(c) Opinion of Jennifer Henkel, Esq., Director and Assistant General Counsel of the Company. (5)(d) Opinion of Fried, Frank, Harris, Shriver & Jacobson LLP, which is referred to in the opinion filed as Exhibit (5)(c). (23)(a) Consent of Jennifer Henkel, Esq., which is contained in her opinion filed as Exhibit (5)(a). (23)(b) Consent of Fried, Frank, Harris, Shriver & Jacobson LLP, which is contained in the opinion filed as Exhibit (5)(b). (23)(c) Consent of Jennifer Henkel, Esq., which is contained in her opinion filed as Exhibit (5)(c). (23)(d) Consent of Fried, Frank, Harris, Shriver & Jacobson LLP, which is contained in the opinion filed as Exhibit (5)(d). (104) Cover Page I

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing